Weill David
TransMedics Group, Inc. · Director
Weill David is listed in filings as Director at TransMedics Group, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to TransMedics Group, Inc. (TMDX). The current snapshot covers public activity from May 23, 2025 to May 22, 2026. Reported amounts are shown as $524.3K to $693.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $693k5k shares | SellDec 3, 2025 | $138.64 | $70.15 | |
| $91k732 shares | SellMay 23, 2025 | $123.88 | $70.15 |